Lack of toxicological side-effects in silver-coated megaprostheses in humans

被引:269
作者
Hardes, Jendrik
Ahrens, Helmut
Gebert, Carsten
Streitbuerger, Arne
Buerger, Horst
Erren, Michael
Gunsel, Andreas
Wedemeyer, Christian
Saxler, Guido
Winkelmann, Winfried
Gosheger, Georg
机构
[1] Univ Munster, Dept Orthopaed, D-48149 Munster, Germany
[2] Inst Pathol, D-33098 Paderborn, Germany
[3] Univ Munster, Inst Clin Chem & Lab Med, D-48149 Munster, Germany
[4] Univ Munster, Environm Specimen Bank Human Tissues, D-48149 Munster, Germany
[5] Univ Duisburg Essen, Dept Orthopaed Surg, D-45122 Essen, Germany
关键词
antimicrobial; antibacterial; bone; metal ion release; metal ion toxicity; metal surface treatment;
D O I
10.1016/j.biomaterials.2007.02.033
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Deep infection of megaprostheses remains a serious complication in orthopedic tumor surgery. Furthermore, reinfection gets a raising problem in revision surgery of patients suffering from infections associated with primary endoprosthetic replacement of the knee and hip joint. These patients will need many revision surgeries and in some cases even an amputation is inevitable. Silver-coated medical devices proved their effectiveness on reducing infections, but toxic side-effects concerning :ionic silver applications have been described as well. Our study reports about a silver-coated megaprosthesis for the first time and can exclude side-effects of silver-coated orthopedic implants in humans. The silver-levels in the blood did not exceed 56.4 parts per billion (ppb) and can be considered as non-toxic. Additionally we could exclude significant changes in liver and kidney functions measured by laboratory values. Histopathologic examination of the periprosthetic environment in two patients showed no signs of foreign body granulomas or chronic inflammation, despite distant effective silver concentrations up to 1626 ppb directly related to the prosthetic surface. In conclusion the silver-coated megaprosthesis allowed a release of silver without showing any local or systemic side-effects. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2869 / 2875
页数:7
相关论文
共 43 条
[1]   Endoprosthetic replacement of the distal tibia and ankle joint for aggressive bone tumours [J].
Abudu, A ;
Grimer, RJ ;
Tillman, RM ;
Carter, SR .
INTERNATIONAL ORTHOPAEDICS, 1999, 23 (05) :291-294
[2]   Prevention of sepsis in total joint arthroplasty [J].
An, YH ;
Friedman, RJ .
JOURNAL OF HOSPITAL INFECTION, 1996, 33 (02) :93-108
[3]   A new method for screening anti-infective biomaterials [J].
Bechert, T ;
Steinrücke, P ;
Guggenbichler, JP .
NATURE MEDICINE, 2000, 6 (09) :1053-1056
[4]   Development and characterisation of silver-doped bioactive glasscoated sutures for tissue engineering and wound healing applications [J].
Blaker, JJ ;
Nazhat, SN ;
Boccaccini, AR .
BIOMATERIALS, 2004, 25 (7-8) :1319-1329
[5]   Silver coated materials for external fixation devices:: in vitro biocompatibility and genotoxicity [J].
Bosetti, M ;
Massè, A ;
Tobin, E ;
Cannas, M .
BIOMATERIALS, 2002, 23 (03) :887-892
[6]  
Butany J, 2000, J HEART VALVE DIS, V9, P129
[7]   The treatment of metastases in the appendicular skeleton [J].
Capanna, R ;
Campanacci, DA .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2001, 83B (04) :471-481
[8]  
CHAMBERS CW, 1962, J AM WATERWORKS ASS, P206
[9]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[10]  
DAHLBERG PJ, 1995, INFECT CONT HOSP EP, V16, P506